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BRIEF DEFINITIVE REPORT
            CD4 T cells that produce IL-17 (IL-17A) have 
been recognized as a Th cell lineage distinct 
from Th1 and Th2, termed Th17 (  1  ). Th17 cells 
are critical mediators of destructive tissue in-
fl  ammation in several animal models of chronic 
infl  ammation (  2  ). Cytokines typically produced 
by Th17 cells, such as IL-17, IL-17F, and IL-22, 
are also found in elevated levels in several hu-
man infl  ammatory diseases ( 3  ). Genetic evidence 
for a putative etiological link of Th17 with hu-
man disease emerged from the association of 
polymorphisms in the IL-23R to altered suscep-
tibility to infl  ammatory bowel disease (IBD), 
psoriasis, and ankylosing spondylitis (  4  ). The IL-
23R can be expressed on a variety of cells (  5  ) but 
is most characteristically associated with cells of 
the Th17 lineage (  2, 6  ). Recently, T cell clones 
displaying characteristics of Th17 cells could be 
propagated from disease-aff  ected sites in psoriasis, 
rheumatoid arthritis, and Crohn  ’  s disease (CD) 
(  7, 8  ). Comparison of the Th17 clones with Th1 
and Th2 clones obtained from the same infl  am-
matory infi  ltrate confi  rmed Th17-specifi  c expr  es-
sion of factors such as IL-23R, the transcription 
factor ROR    T, and the chemokine receptor 
CCR6. However, because in vitro  –  expanded 
T cell clones were analyzed, it has remained 
unclear how Th17 cells are involved in the dis-
ease process. 
  In addition to previously recognized Th17 
hallmarks, analyses of such Th17 clones revealed 
specifi  c expression of CD161 (  9  ). CD161 is a 
C-type lectin-like receptor that is also expressed 
on subsets of NK and CD8 T cells (  10  ). CD161 
has been described as a coactivating receptor 
promoting antigen-dependent T cell prolifera-
tion upon engagement via its recently identifi  ed 
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  The C-type lectin-like receptor CD161, which has recently been described to promote 
T cell expansion, is expressed on a discrete subset of human CD4 T cells. The function of 
such cells, however, has remained elusive. We now demonstrate that CD161  +   CD4 T cells 
comprise a circulating and gut-resident T helper 17 (Th17) cell population. During 
Crohn  ’  s disease (CD), these CD161  +   cells display an activated Th17 phenotype, as indi-
cated by increased expression of interleukin (IL)-17, IL-22, and IL-23 receptor. CD161  +   
CD4 T cells from CD patients readily produce IL-17 and interferon      upon stimulation 
with IL-23, whereas, in healthy subjects, priming by additional infl  ammatory stimuli such 
as IL-1     was required to enable IL-23  –  induced cytokine release. Circulating CD161  +   
Th17 cells are imprinted for gut homing, as indicated by high levels of CC chemokine 
receptor 6 and integrin     7 expression. Supporting their colitogenic phenotype, CD161  +   
Th17 cells were found in increased numbers in the infl  ammatory infi  ltrate of CD lesions 
and induced expression of infl  ammatory mediators by intestinal cells. Our data identify 
CD161  +   CD4 T cells as a resting Th17 pool that can be activated by IL-23 and mediate 
destructive tissue infl  ammation. 
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CD161  +   and CD161        CD4 T memory cell subsets after FACS 
purifi  cation (Fig. S1 D) confi  rmed the fl  ow cytometry results, 
revealing   >  10-fold higher levels of   il23r   expression in CD161  +   
cells (  Fig. 1 B  ). In addition, CD161  +  , as compared with 
CD161       , CD4 T memory cells expressed 3  –  10-fold higher 
levels of mRNA for IL-17 and IL-22 but not IFN-     (  Fig. 1 C  ). 
Consistent with their transcriptional Th17 signature, CD161  +   
CD4 T memory cells were the major source of IL-17 protein 
in the intestine (  Fig. 1 D  ). 
  CD161  +   CD4 T cells can also be found in the circulation, 
where they comprise     20% of CD4 T lymphocytes, and, 
similar to the intestine, exhibit a memory phenotype (  13  ). 
According to a recent study, IL-17-production is attributed 
to such CD161  +   CD4 T cells when compared with total 
CD161        CD4 T cells (  9  ). To confi  rm the Th17 nature of 
circulating CD161  +   CD4 T cells, we selectively focused 
on CD25-depleted memory CD4 T cells to avoid enrich-
ment for naive and regulatory T cells in the CD161        
fraction. Indeed, elevated levels of   il17  ,   rorc  , and   il23r   tran-
scripts were found in CD161  +   as compared with CD161        
CD4  +  CD25       CD45RA        T memory cells (  Fig. 1 E  ). Expres-
sion of commonly Th1-associated factors   il12rb2  ,   ifng  , and 
  tbx21   (the gene encoding T-bet) did not diff  er signifi  cantly 
between the two subsets (  Fig. 1 E  ). A Th17 phenotype was 
also refl  ected in the TCR-mediated cytokine production pat-
tern of CD161  +   CD4 T memory cells (  Fig. 1 F  ), indicating 
that circulating and gut-resident CD161  +   CD4 T memory 
cells constitute a peripheral Th17 pool. 
  Tracking the phenotype of CD161  +   CD4 T cells thus 
enabled us to follow the involvement of Th17 in CD in-
fl  ammation. We observed markedly increased IL-17 produc-
tion in the blood of CD patients, which was confi  ned to 
CD161  +   cells (  Fig. 2 A  ).   IFN-      –  producing cells were pres-
ent in similar levels in both T memory cell subsets (  Fig. 2 B  ). 
Cells expressing both IL-17 and IFN-     were only found 
among CD161  +   CD4 T memory cells as a minor fraction, 
with no signifi  cant diff  erence between health and disease 
(Fig. S2, available at http://www.jem.org/cgi/content/full/
jem.20081712/DC1). The enhanced IL-17 production in 
CD161  +   cells was accompanied by a signifi  cant increase of 
IL-23R  +   cells (  Fig. 2 C  ). Culturing CD161  +   CD4 T mem-
ory cells from normal or CD donors confi  rmed their altered 
activation state during disease: TCR-mediated IL-17 and 
IL-22 but not IFN-     production was increased in CD161  +   
cells from CD patients (  Fig. 2 D  ). Addition of IL-23 induced 
a 1.6-fold median increase in IL-17 production and a 2.2-
fold median increase in IFN-     production in CD patients 
while minimally aff  ecting cytokine levels in healthy donors 
(1- and 1.2-fold, respectively;   Fig. 2 E  ). 
  The distinct IL-23 responsiveness in purifi  ed CD161  +   
cells from CD patients suggested that the infl  ammatory mi-
croenvironment provides crucial cosignals for IL-23. Cor-
roborating the notion of IL-1    , particularly, as an important 
co-stimulator of diff   erentiated Th17 cells (  20  ), CD161  +   
CD4 T memory cells express higher levels of the IL-1     
receptor IL-1R1 than their CD161        counterparts in both 
ligand PILAR (  11  ). In adults, CD161  +   CD4 T cells are pres-
ent in the intestine and in the circulation of healthy people 
(  12, 13  ) but were also found in rheumatic joints and psoriatic 
lesions (  14, 15  ). Recently, it was shown that CD161  +   T cells 
from the infl  ammatory infi  ltrate in psoriasis and CD were 
enriched for IL-17 producers (  9  ). CD, one of the two most 
common forms of IBD, displays a particularly strong connec-
tion to Th17 infl  ammation; genome-wide studies not only as-
sociated polymorphisms in the IL-23R with increased disease 
susceptibility but also single nucleotide polymorphisms in ad-
ditional components of the Th17 pathway (i.e.,   stat3  ,   p40  , 
  jak2  , and   ccr6  ) (  16  ). CD is believed to be the result of an aber-
rant response of the gut-associated lymphoid tissue to bacterial 
and dietary antigen. Although the presence of Th17 cells in 
the infl  amed intestine has been demonstrated (  7  –  9  ), their con-
tribution to the disease process has remained elusive. 
  CD4  +   T cells comprise the major lymphocyte subset in 
the normal intestinal lamina propria and mostly display a 
memory/eff  ector phenotype (  17  ), with a discrete subset ex-
pressing CD161 (  12, 18  ). In light of the proposed link of 
CD161 with IL-17  –  producing cells (  9  ), we hypothesized that, 
similar to observations in mice (  19  ), a gut-resident Th17 pop-
ulation also exists in humans, and set out to (a) identify the 
physiological Th17 cell pool and (b) characterize the involve-
ment of these infl  ammatory cells in human disease. By exam-
ining surgical gut resections and blood specimens from CD 
patients and non-IBD controls, we identify the CD161  +   pop-
ulation of CD4 T memory cells in the intestine and circula-
tion to express hallmarks of the Th17 pathway (i.e., IL-23R, 
ROR    T, IL-17, and CCR6). Furthermore, we defi  ne their 
contribution to systemic and local infl  ammation during CD, 
and demonstrate that these cells can be activated by IL-23 in 
an infl  ammatory environment to release proinfl  ammatory cy-
tokines. Thus, our data show that CD161  +   CD4 T cells com-
prise the physiological Th17 cell pool that can be activated by 
IL-23 during infl  ammation. 
    RESULTS AND DISCUSSION   
  The intestine harbors a large fraction of the body  ’  s T cells. To 
investigate if the human intestinal T cells comprise a popula-
tion of Th17 cells, as observed in mice, we isolated the lamina 
propria mononuclear cell (LPMC) fraction from freshly ob-
tained normal adjacent colonic tissue derived from surgery 
for colorectal cancer or diverticulosis, and analyzed the T 
helper cell compartment. As expected, the majority of lamina 
propria CD4 T cells displayed a memory/eff  ector phenotype 
(CD45RO  +  , CD45RA       ; SD = 73.4   ±   9.2%; Fig. S1 A, avail-
able at http://www.jem.org/cgi/content/full/jem.20081712/
DC1) and contained a signifi  cant proportion of cells ex-
pressing CD161 (SD = 64.3   ±   12.1%; Fig. S1 B). CD161  +   
CD4 T cells exclusively exhibit a memory/eff  ector phenotype 
(CD45RO  +  , CD45RA       ; Fig. S1 C). Analysis of the CD4 T 
cell compartment for IL-23R expression, a hallmark of Th17 
cells, revealed that CD161  +   CD4 T memory cells contained a 
higher frequency of cells positive for IL-23R than their nega-
tive counterparts (  Fig. 1 A  ).   Transcriptional analysis of the JEM VOL. 206, March 16, 2009  527
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these eff  ects nor did it induce proliferation by itself (  Fig. 3 D  ). 
To address whether the increase in cell number was respon-
sible for the increased cytokine production after IL-1     
stimulation, we measured the relative expression of   il17  , 
  ifng  , and   il22   genes, which is independent of cell number. 
The overall trend of cytokine transcript expression resem-
bled the pattern of protein levels; if anything, the eff  ect of 
IL-23, particularly, on IL-17 expression by IL-1      –  primed 
CD161  +   CD4 T cells was more pronounced on the tran-
scriptional level (4.4-fold mean increase;   Fig. 3 E  ; and 
Fig. S3, available at http://www.jem.org/cgi/content/full/
jem.20081712/DC1). Thus, although IL-1     aff  ects prolif-
eration and cytokine production, IL-23 adds to the fi  nal 
diff  erentiation of primed Th17 cells by fi  ne tuning their 
cytokine expression profi  le. Accordingly, cytokine produc-
tion in CD161  +   CD4 T memory cells from CD patients 
was most pronounced after stimulation with IL-23 in con-
junction with IL-1     (  Fig. 3 F  ). 
healthy and CD donors (  Fig. 3 A  ).   Stimulation of normal 
CD161  +   CD4 T memory cells with IL-1     drove IL-17, IL-
22, and IFN-     production, which was, particularly for IL-17 
and IFN-    , further amplifi  ed by the addition of IL-23 (2.4- 
and 1.8-fold mean increase, respectively;   Fig. 3 B  ). In CD161        
CD4 T memory cells, co-stimulation with IL-1     and IL-23 
failed to induce signifi  cant levels of theses cytokines, under-
lining the unique responsiveness of CD161  +   CD4 T memory 
cells to Th17-promoting signals. 
  To understand the basis of IL-1     and/or IL-23 actions, 
we assessed the eff  ect on cell survival and proliferation. The 
rate of apoptosis was similar across all culture conditions (SD = 
7.1   ±   1.7%; not depicted). In addition, there was no diff  er-
ence in the intrinsic proliferative capacity between CD161  +   
and CD161        CD4 T memory cells (  Fig. 3 C  ). Addition of 
IL-1    , however, had a signifi  cant though modest eff  ect on 
the proliferation of CD161  +   and, to a lesser extent, CD161        
CD4 T cells (  Fig. 3 D  ). Interestingly, IL-23 neither added to 
    Figure 1.         CD161 expression identifi  es tissue-resident and circulating Th17 cells.   (A  –  D) LPMCs were isolated from non-CD colon specimens. 
(A) Flow cytometric analysis for IL-23R expression gated on CD45RO  + CD4 +   T cells. The plot is representative of fi  ve independent donors. (B  –  D) CD4  + CD45RO +  
T memory cells were FACS sorted for CD161 expression.   il23r   (B; data are from three individual donors) or   il17 ,   il22  , and   ifng   (C; data are representative of 
two donors) expression was assessed by qRT-PCR and normalized to ubiquitin. Cells were cultured for 3 d with anti-CD2/anti-CD3/anti-CD28 activation 
beads for measurement of IL-17 production (D; data are from two different donors). The dashed line indicates the lower limit of detection. (E and F) PBMCs 
from healthy donors were FACS sorted for CD161  +   and  CD161       CD4 + CD25     CD45RA       T memory cells, and gene expression was profi  led (E; data are from 
four different donors; the dashed line indicates twofold change). The boxes indicate interquartile range with median, and whiskers defi  ne minimum to 
maximum values. Cytokine production was determined after 3 d of culture with anti-CD2/anti-CD3/anti-CD28 activation beads. (F; data are representa-
tive of at least three donors from independent experiments).     528 HUMAN CD161  +   TH17 CELLS PROMOTE INTESTINAL INFLAMMATION   | Kleinschek et al. 
    Figure 2.         Activated Th17 phenotype in CD161  +   CD4 T memory from CD patients.   PBMCs from healthy donors and CD patients were iso-
lated. (A and B) CD4  + CD25     CD45RA       T memory cells were FACS purifi  ed and cultured with PMA and ionomycin for 4.5 h, and were then stained 
for CD161 and IL-17 (A) or IFN-     (B). FACS plots show cytokine production in relation to CD161 expression from one representative CD case. Box 
plots present cytokine-positive cells as a percentage of CD161  +   or  CD161       CD4 T memory cells. Boxes show the interquartile range (the whiskers 
show minimum to maximum; data are from eight different donors). (C) Flow cytometric analysis of CD161  +   CD4 + CD45RO +   T cells for IL-23R ex-
pression. The box plot shows the frequency of IL-23R  +   cells determined as the mean value of two separate stains per donor. The boxes show data 
from 25 different donors as an interquartile range, with whiskers from the 10  th   to the 90  th   percentile (outliers are displayed as dots). (D) CD161  +  
CD4  + CD45RA     CD25       T memory cells from healthy and CD donors were cultured for 3 d with anti-CD2/anti-CD3/anti-CD28 beads with or without 
IL-23. Supernatant was assessed for IL-17, IL-22, and IFN-    . Data are from nine different donors, and lines connect data points representing the 
same donor. (E) IL-23  –  induced x-fold increase in cytokine production by CD161  +   CD4 + CD45RA     CD25       T memory cells from healthy and CD donors 
calculated from the data depicted in D. The dashed line indicates baseline at onefold change.     JEM VOL. 206, March 16, 2009  529
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    Figure 3.         IL-23 drives IL-17 and IFN-     production by CD161  +   Th17 cells during infl  ammation.   CD161 +   and  CD161       CD45RA     CD25     CD4 +   T 
memory cells were FACS purifi  ed from PBMCs from healthy and CD donors. (A) Expression levels of   il1r1  were determined by qRT-PCR and normalized to 
ubiquitin; data are from fi  ve different donors. Connecting lines indicate data points referring to the same donor. (B  –  F) Cells from healthy (B  –  E) or CD (F) 
donors were cultured for 3 d with anti-CD2/anti-CD3/anti-CD28 beads only or with the addition of IL-23 and/or IL-1     as indicated. (B) Protein levels for 
IL-17, IL-22, and IFN-     in culture supernatant from normal CD4 T memory cells. Data shown from 8 donors are representative of 15 donors from indepen-
dent experiments. (C and D) Frequency of viable cells was measured in a colorimetric assay based on enzymatic activity. Cell viability after culture without 
cytokine stimulation (C) was set as the 100% value to calculate cytokine-induced proliferative responses per donor (D). The bar diagram represents mean 
values for the eight different donors depicted in C (error bars = SD). The dashed line indicates baseline proliferation in cultures without cytokine stimula-
tion set as 100% value. (E) Transcriptional expression of   il17 ,   il22  , and   ifng   in T cells from healthy donors was assessed by qRT-PCR. CD161  +   cells from 11 
different donors were analyzed with corresponding analysis for CD161        cells from 4 of those donors. (F) IL-17, IL-22, and IFN-     protein levels in culture 
supernatant from CD patients  ’   T cells. Data are shown for eight different donors. IL-17 levels for CD subject no. 8 exceeded the scale (values for CD161  +  
cells with values for CD161        cells in brackets: media, 4,298 [497] pg/ml; IL-23, 7,198 [1,248] pg/ml; IL-1    , 7,943 [946] pg/ml; and IL-23 + IL-1   ,  10,911 
[1,386] pg/ml). Individual symbols represent individual donors to visualize trends per donor (B, E, and F). Horizontal bars represent medians (B, C, E, and F).     
  Having shown that CD161  +   Th17 cells can be potently 
activated in an infl  ammatory environment, we now explored 
their role in sustaining end-organ infl  ammation, as defi  ned by 
their potential to (a) migrate to the disease-aff  ected sites and 
(b) induce local tissue infl  ammation. Cell traffi   cking from the 
blood into areas of active infl  ammation requires the expression 530 HUMAN CD161  +   TH17 CELLS PROMOTE INTESTINAL INFLAMMATION   | Kleinschek et al. 
regulate it (  Fig. 4 B  ). Because surface expression of CCR6 has 
recently been attributed to Th17 cells (  7, 23  ), these results not 
only confi  rm the infl  ammatory potential but also the Th17 
phenotype of CD161  +   CD4 T memory cells. 
  When primed by intestinal DCs, T cells up-regulate the 
gut homing receptor integrin     7 (  24  ). CD161  +   CD4 T cells 
from normal blood manifested a higher frequency of integrin 
    7  +   cells than CD161        T cells, indicating the intestine as 
their initial site of priming (  Fig. 4 C  ). Moreover, such inte-
grin     7  +   CD161  +   CD4 T memory cells coexpressed integrin 
of the appropriate homing and chemokine receptors. In partic-
ular, the chemokine receptor CCR6 facilitates CD4 T mem-
ory cell traffi   cking to epithelial sites ( 21  ), and its sole chemokine 
ligand, CCL20 (MIP-3    ), is highly expressed at sites of CD in-
fl  ammation (  22  ). In healthy subjects, a mean of 67.9% (  ±  12.3% 
SD) of CD161  +   CD4 T memory cells was positive for CCR6 
as compared with 34.6% (  ±  12% SD) of their CD161        coun-
terparts (  Fig. 4 A  ).   The proportion of CCR6 expression was 
not altered during disease: CD161  +   cells maintained high ex-
pression of this receptor, whereas CD161        cells failed to up-
    Figure 4.         CD161  +   Th17 cells are imprinted for gut homing and contribute to the infl  ammatory infi  ltrate in CD.   (A – E)  PBMCs  from  healthy 
donors and CD patients were isolated and analyzed by fl  ow cytometry. The proportion of CCR6  +   cells of normal (A and B) and CD (B) CD161  +   and  CD161      
CD4  + CD45RO +   T memory cells. Stains were performed in duplicates, and the mean value per donor from 14 different healthy and CD donors is shown. 
(C) Distribution of integrin    7 +   cells gated on total normal CD4  + CD45RA       T memory cells (left), and distribution of integrin    4 +   cells gated on total normal 
integrin    7 +   CD4 + CD45RA       T memory cells (right; data are representative of eight different donors). (D and E) Frequency (D) or mean fl  uorescence inten-
sity (MFI; E) of integrin    7 +   cells of either CD161  +   or  CD161       CD4 + CD45RA       T memory cells from healthy donors and CD patients; data are from 12 dif-
ferent healthy and 14 different CD donors. (F  –  H) LPMCs were isolated from CD and control patients  ’   colon resections. The total number per full thickness 
tissue weight (F) and frequency (G) of CD161  +   CD4 T cells were determined by fl  ow cytometry. n.a., no tissue weight available. (H) fl  ow cytometric analysis 
of LPMCs for CCR6 and     7-integrin expression gated on CD161  +   CD4 + CD45RA       T memory cells. Plots show data from three different experiments with 
two different control and two different CD cases, and nonlesional tissue available from one CD patient. Horizontal bars represent  medians  (B  and  D – G).     JEM VOL. 206, March 16, 2009  531
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  To investigate whether CD161  +   T cells indeed contribute 
to CD infl  ammation, we analyzed the composition of the intes-
tinal infl  ammatory infi  ltrate. Mononuclear cell isolations from 
CD gut resections revealed a 20-fold increase of CD161  +   CD4 
T cells as compared with control specimens (  Fig. 4 F  ). More-
over, these CD161 expressers presented the predominant subset 
of infi  ltrating CD4 T cells (  Fig. 4 G  ). Because the gut physio-
logically contains a high frequency of CD161  +   CD4 T cells, we 
assessed these cells for phenotypical diff  erences in health and 
disease. The frequency of intestinal integrin     7  +   CD161  +   CD4 
T memory cells was dramatically increased during CD (  Fig. 4 H  ), 
consistent with the hypothesis that recirculating cells contribute 
to the increase in total numbers. Interestingly, all such integrin 
    7  +   cells coexpressed CCR6, indicating the Th17 nature of the 
infi  ltrate (  Fig. 4 H  ). 
  Th17-derived cytokines, including IL-17, IL-17F, and 
IL-22, have been shown to induce expression of infl  ammatory 
mediators by intestinal cells (  28  ). Given the selective association 
    4 (  Fig. 4 C  ). Integrin     7, when in complex with integrin 
    4, binds the gut-specifi  c mucosal addressin cellular adhesion 
molecule 1 (MAdCAM-1) (  25  ). During CD, MAdCAM-1 is 
up-regulated in the intestinal vasculature, potentiating the re-
cruitment of integrin     4    7  +   cells to disease-aff  ected sites (  26  ). 
In this context, it was intriguing that in CD patients the fre-
quency of circulating integrin     7  +   CD161  +   CD4 T cells was 
notably decreased (  Fig. 4 D  ). The hereby suggested sequestra-
tion of such cells in the intestine was supported by another 
fi  nding: CD161  +   CD4 T memory cells from healthy donors 
presented a higher per cell ratio of integrin     7 than CD161        
cells (  Fig. 4 E  ). In CD patients, however, the remaining inte-
grin     7 expressers displayed a signifi  cant reduction in the 
mean fl  uorescent intensity of integrin     7 staining (  Fig. 4 E  ). 
It has been previously reported that binding to MAdCAM-1 
is favored by dense expression of integrin     7 (  27  ), indicating 
that integrin     7  bright   CD161  +   CD4 T cells preferentially parti-
tion to the intestine during disease. 
    Figure 5.         Activated CD161  +   Th17 cells promote intestinal infl  ammation.   CD161 +   and  CD161       CD4 + CD45RA     CD25       T memory cells were purifi  ed 
from normal PBMCs. Cells were cultured for 3 d in the presence of anti-CD2/anti-CD3/anti-CD28 activation beads with or without IL-23 and IL-1   .  Cell-
free supernatant was used to stimulate HT-29 colonic epithelial cells (A and B) or 18Co colonic myofi  broblasts (C). (A) Chemokines in HT-29 supernatant 
were measure by ELISA. Data for three T cell donors are shown as representative of eight different donors. (B) Supernatant from IL-23/IL-1    – activated  T 
cells was used to stimulate HT-29 cells. Where indicated, the supernatant was pretreated with monoclonal anti  –  IL-17 and/or IL-22BP to neutralize the 
respective cytokine. Chemokine levels after stimulation with untreated supernatant from CD161  +   CD4 T memory cells were set as the100% value for each 
donor (dashed line), and expression for all other stimulations is shown as the percentage thereof. Individual symbols refer to individual donors. Data show 
fi  ve T cell donors from three different experiments. Horizontal bars represent medians. (C) Transcriptional expression of CCL20, IL-6, and TNF in stimulated 
18Co cells was measured by qRT-PCR and is depicted as the mean and SD for two different T cell donors.     532 HUMAN CD161  +   TH17 CELLS PROMOTE INTESTINAL INFLAMMATION   | Kleinschek et al. 
the Th2-specifi  c prostaglandin receptor CRTh2, illustrate the 
complexity of lineage-controlling signals (  30  ). The identifi  ca-
tion of CD161, a C-type lectin-like receptor with homology 
to CD69, points at additional co-stimulatory pathways in the 
Th17 response: the role of CD161 in supporting activation-
induced T cell expansion paired with its selective expression 
on Th17 cells could potentially make it an attractive thera-
peutic target in CD and other related diseases. 
  MATERIALS AND METHODS 
  Patients and blood donors.     Fresh colon specimens were obtained from pa-
tients undergoing surgery for CD or noninfl  ammatory diseases such as colorectal 
cancer or diverticulosis from the University of Michigan (reviewed and approved 
by the University of Michigan Institutional Review Board), the Cooperative 
Human Tissue Network at Vanderbilt University (reviewed and approved by 
Independent Review Consulting), or Asterand (all studies through which 
Asterand acquires human tissue specimens are approved and overseen by either 
local or central institutional review boards, and are reviewed by Asterand ’  s Quality 
Assurance Department). All samples were collected from surplus surgical material 
with fully informed patient consent. Tissues were reexamined by a pathologist. 
Blood was obtained from CD patients and healthy individuals scheduled for a 
routine colonoscopy at the Mayo Clinic (approved by the Mayo Clinic Institu-
tional Review Board), as well as healthy adult volunteer donors participating in 
the Stanford Medical School Blood Center blood donation program, in accor-
dance with the Declaration of Helsinki. For CD samples, patients with a known 
history of CD were enrolled, and activity at the time of blood draw was assessed 
by colonoscopy, followed by pathological examination of biopsies. 
  Isolation of mononuclear cells.     LPMCs were isolated from surgical colon 
resections according to an established protocol (  31  ) modifi  ed to not exceed 
6 h. In brief, isolated mucosa was incubated in HBSS-CMF containing 3 mM 
    ME to dissolve mucus, followed by repeated incubations with 5 mM EDTA in 
HBSS-CMF to dissociate the epithelial layer. Washed lamina propria was then 
cut into small pieces and digested during repeated incubations in collagenase and 
DNase containing complete RPMI 1640 at 37  °  C in a shaking water bath. Cells 
were used for FACS analysis and gene expression profi  ling or cultured over-
night, and the nonadherent cell fraction was further processed for T cell subset 
purifi  cation. LPMCs were cultured overnight and the nonadherent cell fraction 
was further processed. PBMCs were isolated as previously described (  6  ). 
  Flow cytometry and cell sorting.     Surface expression analysis of LPMCs and 
PBMCs was performed according to standard protocols using antibodies from 
BD, except for anti  –  IL-23R (biotinylated polyclonal goat anti  –  human; R  &  D 
Systems), with streptavidin  –  Pacifi  c blue (BD) as secondary reagent. For intracel-
lular cytokine staining, CD4  +  CD45RA       CD25        T memory cells were FACS 
sorted from healthy and CD PBMCs on a FACSAria (BD), and were stimulated 
with PMA and ionomycin in the presence of GolgiPlug (BD) for 4.5 h. Cells 
were permeabilized using Cytofi  x/Cytoperm reagents (BD) and were incubated 
with anti  –  IFN-     (BD) and anti  –  IL-17A (eBioscience). CD161  +   and CD161        
cells were purifi  ed from total LPMCs or PBMCs in a two-way sort gated on 
CD4  +  CD45RO  +   (LPMCs) or CD4  +  CD25       CD45RA        (PBMCs) T memory 
cells using a FACSAria. 
  Cell culture.     T cells were cultured with anti-CD2/anti-CD3/anti-CD28 
activation beads for 3 d, as previously described (  6  ). For certain experiments, 
IL-23 and IL-1     were added at 50 ng/ml. The intestinal cell lines HT-29 and 
18Co (American Type Culture Collection) were cultured with 10% T cell su-
pernatant for 1 d. Neutralization of IL-17 and/or IL-22 function was achieved 
by preincubation of T cell supernatant for 1 h with monoclonal anti  –  IL-17A 
and/or IL-22BP (both from R  &  D Systems). 
  Cytokine measurement and assessment of viability.     IFN-y, IL-17, IL-22, 
CXCL5, and CXCL8 were measured using Quantikine kits (R  &  D Systems). 
An IL-17F electrochemiluminescence assay was developed in-house for the 
of CD161  +   CD4 T cells with the gut, we then asked whether 
these cells were particularly biased toward inducing intestinal 
tissue infl  ammation. Treatment of HT-29 colon epithelial cells 
with supernatant from IL-1      –   and IL-23  –  activated CD161  +   
cells compared with CD161        cells led to increased expression 
of CXCL5, CXCL8, and CCL20, chemokines known to sus-
tain the infl  ammatory process during CD (  Fig. 5 A  ).   CD161  +   
CD4 T cell  –  induced chemokine expression was signifi  cantly 
reduced after neutralization of IL-22 and, in the case of CCL20, 
IL-17 activity, and reached levels similar to CD161        T cell  –  in-
duced expression (  Fig. 5 B  ). Interestingly, neither recombinant 
IL-17 or IL-22, nor the combination of both, was suffi   cient to 
induce detectable levels of any of those factors (unpublished 
data). Thus, our results demonstrate that Th17 cytokines defi  ne 
the infl  ammatory potential of CD161  +   CD4 T cells but that 
these molecules have to act in concert with the infl  ammatory 
microenvironment. The even broader implication of CD161  +   
CD4 T cells in mediating the infl  ammatory response became 
evident when we analyzed another cell type, 18Co intestinal 
myofi  broblasts, for their response to activation with T cell su-
pernatant: in addition to CCL20, these cells also expressed ele-
vated levels of IL-6 and TNF-    , two key mediators of tissue 
destruction in CD (  Fig. 5 C  ). 
  In conclusion, we have identifi   ed a CD161-expressing 
subpopulation of circulating and gut-resident CD4 T memory 
cells with a unique ability to respond to IL-23 to become fully 
diff  erentiated/activated Th17 cells, and demonstrate their 
central involvement in chronic target-organ infl  ammation 
(Fig. S4, available at http://www.jem.org/cgi/content/full/
jem.20081712/DC1). Recently, Cosmi et al. isolated CD161  +   
CD4 T cells from umbilical cord blood as well as postnatal thy-
mus, and demonstrated their early commitment to the Th17 
lineage (  9  ). It is conceivable that these cells present precursors 
of the herein described CD161  +   T memory cell population, 
which during the development of the immune system mature 
and as precommitted CD161  +   Th17 cells selectively partition 
to the intestine, where they eventually present a distinct Th 
cell subset. Devoid of an infl  ammatory environment, these 
CD161  +   T cells are protected from the critical impact of IL-
23 activation. Introduction of infl  ammatory stimuli, however, 
releases this inhibition: a single, potent proinfl  ammatory cyto-
kine (IL-1    ) was able to license purifi  ed CD161  +   CD4 mem-
ory cells for activation by IL-23. Importantly, CD161  +   T cells 
isolated from CD patients  ’   blood displayed an enhanced Th17 
phenotype and were capable of responding to IL-23 in the 
absence of any infl  ammatory co-stimulus. It will be interesting 
to decipher whether this indicated an in situ activation before 
isolation or rather a disease-specifi  c intrinsic defect leading to 
inappropriate IL-23 responsiveness. 
  The factors involved in Th cell diff   erentiation and in 
shaping their eff  ector functions leave a lineage-specifi  c fi  n-
gerprint on the surface. In these regards, phenotypical charac-
terization of cytokine and chemokine receptor expression has 
been instrumental in defi  ning Th cell subsets and understand-
ing their biology. In addition, the diff  erential expression of 
TIM family members on Th1 and Th2 cells (  29  ), as well as JEM VOL. 206, March 16, 2009  533
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Meso Scale Discovery (MSD) platform, as previously described (  6  ). Simulta-
neous detection of IL-17 and IFN-     in the culture supernatant of CD pa-
tients  ’   T cells was performed by electrochemiluminesence in a custom MSD 
multiplex assay. Apoptosis was measured by Annexin V and propidium 
iodide staining (Apoptosis Kit; BD). Proliferation was assessed using a 
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  Gene expression profi  ling.     RNA was isolated from cell pellets and gene 
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  Online supplemental material.     Fig. S1 depicts fl  ow cytometric analysis of 
LPMCs showing that the majority of colonic CD4 T cells express CD45RO 
and CD161. Fig. S2 shows that the small proportion of IL-17 and IFN-     
double producers in the circulation is contained within the CD161  +   CD4 T 
memory cell compartment. Fig. S3 shows the x-fold increase of IL-1      –  in-
duced cytokine transcript or protein expression by CD161  +   Th17 cells after 
stimulation with IL-23. Fig. S4 summarizes the herein reported fi  ndings in 
an illustration proposing a model for the central role of CD161  +   Th17 cells 
in promoting intestinal infl  ammation. Online supplemental material is avail-
able at http://www.jem.org/cgi/content/full/jem.20081712/DC1. 
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